Cyabra director granted 14,436 stock options
CYABRA, INC. director Michael P. Madon received a fully vested stock option grant tied to the company’s recent business combination.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CYABRA, INC. director Michael P. Madon received a fully vested stock option grant tied to the company’s recent business combination. The award covers options to buy 14,436 shares of common stock at an exercise price of $1.00 per share, expiring on January 8, 2035.
According to the footnotes, this option replaces a prior Cyabra Strategy Ltd. option for 4,000 ordinary shares under the merger agreement with Trailblazer Merger Corporation I. After this grant, Madon holds options covering 14,436 shares, reflecting compensation and equity alignment following the transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option(Right to Buy) | 14,436 | $0.00 | $0.00 |
Footnotes (3)
- F1. The options were fully vested upon grant.
- F2. Received in connection with the Issuer's business combination with Trailblazer Merger Corporation I ("Trailblazer"), in accordance with the terms of the Merger Agreement, dated July 22, 2024, as amended (the "Merger Agreement"), by and among Trailblazer, Trailblazer Merger Sub, Ltd. ("Merger Sub"), Trailblazer Holdings, Inc. ("Holdings"), and Cyabra Strategy Ltd. ("Cyabra"), pursuant to which (a) Trailblazer merged with and into Holdings, with Holdings as the surviving entity of the merger (the "Parent Merger"), and (b) Merger Sub merged with and into Cyabra, with Cyabra as the surviving entity of the merger (together with the Parent Merger and all other transactions contemplated by the Merger Agreement, the "Business Combination"), following which Merger Sub ceased to exist and Cyabra became a wholly owned subsidiary of Holdings. After giving effect to the Business Combination, Holdings changed its name to the Issuer.
- F3. Pursuant to the Merger Agreement, each option to purchase ordinary shares of Cyabra held by the Reporting Person that was outstanding immediately prior to the effective time of the Business Combination (the "Effective Time") for an aggregate of 4,000 ordinary shares was, as of the Effective Time, cancelled in consideration for the issuance of an option to purchase shares of the Issuer reported herein, subject to the same terms and conditions as were applicable to the corresponding Cyabra option immediately prior to the Effective Time, pursuant to the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan.
Key Figures
Key Terms
Business Combination financial
Merger Agreement financial
Effective Time financial
Omnibus Equity Incentive Plan financial
stock option financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CYAB (Cyabra, Inc.) director Michael P. Madon receive in this Form 4 filing?
What is the exercise price and expiration date of Michael Madon’s CYAB options?
Were Michael Madon’s CYAB options vested at the time of grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.